Exposure of susceptible neuroblastoma N2a cells to mouse scrapie prions leads to infection, as evidenced by the continued presence of the scrapie form of the prion protein (PrP Sc ) and infectivity after 300 or more cell doublings. We find that exposure to phosphatidylinositol-specific phospholipase C (PIPLC) or to the monoclonal anti-prion protein (PrP) antibody 6H4 not only prevents infection of susceptible N2a cells but also cures chronically scrapie-infected cultures, as judged by the long-term abrogation of PrP Sc accumulation after cessation of treatment. A nonpassaged, stationary infected culture rapidly loses PrP Sc when exposed to the antibody or PIPLC, indicating that the PrP Sc level is determined by steady state equilibrium between formation and degradation, and that depletion of the cellular form of PrP can interrupt the propagation of PrP Sc . These findings encourage the belief that passive immunization may provide a therapeutic approach to prion disease.
T he ''protein only'' hypothesis proposes that the causative agent of transmissible spongiform encephalopathies, the prion, is identical with a conformational isoform of the cellular form of the prion protein (PrP C ) (1) . PrP C is a normal host protein (2-4) that occurs in most organs, but most abundantly in the brain. It carries up to two N-linked glycans, is anchored at the outer surface of the plasma membrane by a glycosylphosphatidylinositol tail, and is associated with caveolae, at least in cultured cells (5, 6) . The abnormal conformer, when introduced into the organism, causes conversion of PrP C into a likeness of itself (1) .
During the course of prion disease, a largely proteaseresistant, aggregated form of PrP, designated PrP Sc , accumulates mainly in brain, and may be the main or only constituent of the prion (2, 7) . Because no differences in primary sequence were found between PrP C and PrP Sc (8) , the two species are believed to differ only in their conformation.
Only few cell lines, mostly derived from neural tissue, such as the N2a, GT1, and PC12 lines (9) (10) (11) (12) , but also an epithelial rabbit cell line (13) , can be infected by scrapie agent, as evidenced by the presence of infectivity and/or PrP Sc after multiple passages, sufficient to eliminate the original inoculum. Only a small fraction of a N2a or GT1 cell population is readily infected by the mouse-adapted Rocky Mountain Laboratory (RML) scrapie strain, but from such populations sublines can be established which are highly susceptible to infection (14, 15) .
We have used the approach of Bosque and Prusiner (14) to isolate N2a sublines susceptible or resistant to RML scrapie prions. Scrapie infection of the susceptible subline N2a/Bos2 is prevented by the monoclonal anti-PrP antibody 6H4 (16) 
Materials and Methods
Cell Culture. Mouse neuroblastoma N2a cells were cultured in OPTI-MEM supplemented with 10% FCS and penicillin G and streptomycin (complete medium) at 37°C in 5% CO 2 /95% air.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Prion Infection of N2a Cells.Brains from scrapie-sick mice infected with RML mouse-adapted prions were homogenized by passing eight times each through 21-and 25-gauge needles and adjusted to 10% (wt/vol) with 1ϫ Dulbecco's phosphate-buffered saline (GIBCO/BRL). After centrifuging for 5 min at 1,000 rpm (Eppendorf Centrifuge 5415c, Hamburg, Germany) and at room temperature, supernatants were recovered and stored at Ϫ80°C. Mouse PrP Sc was partially purified as described (17) . Cells (2-5 ϫ 10 4 in 1 ml of medium) were seeded into 24-well plates (Corning Costar) and cultured for 1-2 days before exposure to either 20 ng/ml purified PrP Sc (RML strain) or RML-infected mouse brain homogenate, diluted as indicated with complete medium. The inoculum was removed after 3 days and the cells were split 1:5 every 3-4 days. After 14 days the cells were assayed for PrP Sc by the cell blot procedure (14) .
Selection of Prion-Susceptible and Prion-Resistant N2a
Sublines. N2a cells were cotransfected with pSVneo (18), which confers neomycin resistance and a plasmid (pEF-Bos-EX; ref. 19 ) containing a ''half-genomic'' PrP transcription unit (20) with the ORF of wild-type PrP, MHM2 PrP (21, 22) , or MH2M PrP (21, 22) , under the control of the EF1␣ promoter. The intention was to generate N2a cell lines that overexpress mouse or hamstermouse hybrid PrP molecules and thereby facilitate infection with mouse and/or hamster prions (22) . As negative control, cotransformation was performed with pSVneo and pEF-BOS-EX devoid of an ORF. After selection in G418 at 0.7 mg/ml, clones of each group were tested for susceptibility to infection by RML scrapie prions, as described above. Clone N2a/Bos2 was selected as the most susceptible subline and aliquots thereof and of N2a/Bos2 cells chronically infected with RML prions were kept at Ϫ80°C.
Cell Blot Assay for PrP Sc . The assay was performed as described (14) . In short, cells were transferred to a poly(vinylidene difluoride) membrane, treated with proteinase K, denatured, immunostained with antibody 6H4 (Prionics) followed by horseradish peroxidase-conjugated goat anti-mouse IgG1, and visualized by enhanced chemiluminescence (ECL kit; Pierce). After exposure, the membrane was stained for 15 min with 0.5 g/ml ethidium bromide and photographed in UV light to document the transfer of the cell layer.
Western Blot Analysis. Samples (15 g total protein) were run through SDS/16% polyacrylamide gels (8 ϫ 8 cm) and transferred to a poly(vinylidene difluoride) membrane by electroblotting at 35 V for 1 h. PrP was detected by incubation with 200 ng/ml monoclonal anti-PrP antibody 6H4 (16) followed by horseradish peroxidase-conjugated goat anti-mouse IgG1 
Results

Isolation of Cell Lines Susceptible and Resistant to RML Scrapie Prions.
N2a cells were transformed with PrP expression (or control) plasmids with the intent of raising their PrP level and thereby rendering them more susceptible to infection with prions from various sources. Transformed clones were assayed for their susceptibility to RML prion infection by an immunoblotting assay (14) (Fig. 1a) . Unexpectedly, the most susceptible line, N2a/Bos2, was derived from cells that had been transformed with the control plasmid. To assess the proportion of cells susceptible to infection, N2a/Bos2 cells were subcloned and assayed by the blotting procedure; 49% of the cells were susceptible to infection (data not shown).
N2a/Bos2 cells and a prion-resistant line, N2a/2M11 (transformed with a PrP expression plasmid), were challenged with mouse-scrapie-infected brain extract at various dilutions and passaged for 2 weeks. N2a/Bos2 cultures became PrP Sc -positive after exposure to scrapie-infected 10% brain homogenate diluted up 10
Ϫ4
, whereas the resistant line remained negative at all dilutions tested (Fig. 1b) .
Surprisingly, the susceptible line N2a/Bos2 expressed PrP at about the same low level as the original N2a cells, whereas the resistant line expressed PrP at a level 10 or more times higher, as shown by Western blot analysis (Fig. 1c) . PrP is essential for prion propagation and scrapie pathogenesis (23, 24) , and overexpression of PrP decreases incubation time in transgenic mice (20, 25) . Nonetheless, overexpression does not increase levels of infectivity in brain (20) , nor do tissues that do not normally produce prions become permissive by ectopic overexpression of PrP (26, 27) . PrP was expressed at the cell surface of all lines, as evidenced by biotinylating intact cells, immunoprecipitating the extracted proteins with anti-PrP antibody, and subjecting them to Western blot assay with horseradish peroxidase-labeled streptavidin (data not shown). Our findings reinforce the conclusion that factors other than PrP are essential for susceptibility to infection by prions (26, 27) .
PIPLC and Anti-PrP Monoclonal Antibody 6H4 Prevent Infection of the Susceptible N2a
Cell Line by Scrapie Prions. Monoclonal anti-PrP antibody 6H4 recognizes residues 144 -152 of murine PrP and thus binds to its helix 1 (16) . PIPLC cleaves the glycosylphosphatidylinositol moiety linking PrP to the outer surface of the plasma membrane, thereby releasing PrP from the cell surface. Antibody 6H4 or PIPLC was added to the medium at various concentrations 2 h before and during exposure of N2a/Bos2 cells to 0.1% scrapie-infected brain homogenate. After 3 days, the cells were washed and further cultured for 2 weeks, splitting 1:5 every 3-4 days. During this period, antibody, but not PIPLC treatment, was continued. As assayed by the blotting procedure after 14 days, antibody 6H4 at 2.5 g/ml and PIPLC at 0.25 unit/ml sufficed to prevent appearance of PrP Sc (Fig. 2a) .
Rapid Loss of PrP Sc Elicited by Anti-PrP Monoclonal Antibody 6H4 and
PIPLC. Chronically prion-infected N2a/Bos2 cells were exposed to various concentrations of antibody 6H4 or PIPLC and cultured on coverslips without passaging. After 3 days, PrP Sc was barely detectable in the case of 6H4 at 3 g/ml and PIPLC at 0.25 unit/ml (Fig. 2b) . No toxic effects were observed. Two other IgG1 monoclonal antibodies, anti-desmin and anti-␤-actin, at concentrations up to 5 g͞ml, did not affect PrP Sc levels (data not shown). After culturing for 2 weeks, splitting 1:5 every 3-4 days, as little as 1 g/ml 6H4 led to disappearance of PrP Sc (Fig. 2c) .
To determine whether the depletion of PrP Sc was transient or permanent, chronically infected N2a/Bos2 cells were cultured for Chronically infected N2a/Bos2 cells, treated with antibody 6H4 for 2 weeks at the concentrations indicated and propagated in its absence for 66 days were not exposed (upper 2 rows) or exposed to 0.1% RML-infected mouse brain homogenate for 3 days (lower 2 rows). After culturing for 14 days, PrP Sc was monitored by the cell blot assay. (b) Relative susceptibility to prions of N2a/ Bos2 cells (BOS2) and N2a/Bos2 cells ''cured'' by exposure to antibody 6H4 at 20 g/ml was determined by exposing cultures to various dilutions of RMLinfected mouse brain homogenate for 3 days and determining PrP Sc as above. (c) Levels of PrP C and PrP Sc in various sublines were determined by Western blotting. Chronically infected N2a/Bos2 cells, treated for 2 weeks with antibody 6H4 at the concentrations indicated, were passaged for 84 days after antibody withdrawal. Cells were lysed and samples corresponding to 2.25 ϫ 10 5 cells were incubated in the presence (ϩPK) or absence (ϪPK) of proteinase K (5 g/ml) for 90 min at 37°C. Western blotting was performed as described in Materials and Methods. UN, uninfected N2a/Bos2 cells; I-BOS2, chronically prion-infected BOS2 cells. Molecular mass markers are indicated at the left of each panel.
2 weeks with various concentrations of antibody 6H4 and subsequently in its absence. Samples assayed 2, 4 (data not shown), or 6 weeks (Fig. 2d) after removal of the antibody were devoid of PrP Sc , in contrast to the chronically infected, untreated cells. ''Cured'' cells were still susceptible to scrapie prion infection ( Fig. 3 a and b) and expressed PrP C at the original level (Fig. 3c) .
Discussion
Expression of PrP C is essential, albeit not sufficient (26, 27) , for prion propagation and pathogenesis (23, 24) , as well as for neuroinvasion after peripheral infection (28) . Surprisingly, the N2a line most susceptible to RML prions we identified expressed PrP C at low levels compared with prion-resistant N2a sublines overexpressing PrP C .
It was suggested early on that suppression of PrP expression might be an approach to the therapy of prion diseases (23) . Several drugs have been shown to diminish or abolish PrP Sc in prion-infected cell cultures, for instance Congo red (29) , polyene compounds such as amphothericin (30) , pentosan sulfate (31), branched polyamines (32) , and ␤-sheet-breaking peptides (33) , to mention but a few. In some instances these drugs delayed, but never prevented, the appearance of clinical symptoms and death in experimental animals (34, 35 (36) , or sequestration and/or reversion of PrP Sc to a protease-sensitive state (33) . In addition, abrogation of PrP C synthesis or prevention of transport to the cell surface could interrupt prion propagation.
In our experiments, 6H4 prevents PrP Sc formation either by occluding PrP C or PrP Sc or both and thereby preventing conversion (Fig. 4) . The finding that exposure of chronically infected N2a cells to PIPLC (or anti-PrP antibody 6H4) causes PrP Sc to disappear almost completely in the course of 3 days, even without splitting of the culture, leads to the conclusion that PrP Sc is rapidly degraded, while the antibody prevents formation of further PrP Sc . Pulse-labeling experiments on N2a cells showed that exposure of scrapie-infected N2a cells to PIPLC prevents the formation of radioactive PrP Sc (37, 38) and indicated a half-life of Ͼ24 h (37), longer than that suggested by our experiments. Because removal of PrP C from the cell surface by PIPLC has the same effect as exposure to PrP antibody, occlusion of PrP C by antibody binding suffices to explain its effect.
The findings that in transgenic mouse models of Alzheimer's disease immunization with amyloid-␤ protein (A␤) causes a marked reduction in burden of the brain amyloid (39, 40) , and that antibodies against the Alzheimer peptide A␤ penetrate the brain-blood barrier and lead to reversal of amyloid deposition (41, 42) , suggest that active or passive immunization to PrP might have a beneficial effect in prion diseases.
We thank Dr. P.-C. Klöhn for his help, and Dr. J. Collinge for support and encouragement. This work was funded by the Medical Research Council. . PrP C is attached to the membrane by a glycosylphosphatidylinositol anchor, and it cycles between the cell surface and an endocytic compartment (43) . In scrapie-infected cells, PrP C is recruited into PrP Sc ''seeds'' (44) , which may be located at the cell surface and/or in the endocytic/lysosomal compartment. PrP Sc is degraded in the lysosomal compartment; if PrP C is prevented from converting to PrP Sc either by a blocking antibody or by being stripped from the cell surface by PIPLC, PrP Sc will diminish and ultimately disappear.
